A carregar...

IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques

BACKGROUND: Despite inducing a sustained increase in CD4+ T cell counts, intermittent recombinant IL-2 (rIL-2) therapy did not confer a better clinical outcome in HIV-infected patients enrolled in large phase III clinical trials ESPRIT and SILCAAT. Several hypotheses were evoked to explain these dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garibal, Julie, Laforge, Mireille, Silvestre, Ricardo, Mouhamad, Shahul, Campillo-Gimenez, Laure, Lévy, Yves, Estaquier, Jérôme
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3499432/
https://ncbi.nlm.nih.gov/pubmed/23021024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-9-220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!